Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Botulinum Toxin Type A Therapy as a Plasticity Inducing Agent for Recovery of Hand Function After Stroke

NCT01422161 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT01422161
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01422161 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Botulinum Toxin Type A Therapy as a Plasticity Inducing Agent for Recovery of Hand Function After Stroke
Lead sponsor
NYU Langone Health
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2010
Completion date
October 31, 2015
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke with hemiparesis